| Title | Restraint of melanoma progression by cells in the local skin environment. |
| Publication Type | Journal Article |
| Year of Publication | 2026 |
| Authors | Ma Y, Tagore M, Hunter MV, Huang T-H, Montal E, Weiss JM, Shi Y, Vallius T, Sorger PK, White RM |
| Journal | Elife |
| Volume | 13 |
| Date Published | 2026 Jun 30 |
| ISSN | 2050-084X |
| Keywords | Animals, Cell Line, Tumor, Coculture Techniques, Disease Models, Animal, Disease Progression, Epithelial-Mesenchymal Transition, Humans, Keratinocytes, Melanoma, Skin, Skin Neoplasms, Tumor Microenvironment, Twist-Related Protein 1, Zebrafish |
| Abstract | Keratinocytes, the dominant cell type in the melanoma microenvironment during tumor initiation, exhibit diverse effects on melanoma progression. Using a zebrafish model of melanoma and human cell co-cultures, we observed that keratinocytes undergo an epithelial-mesenchymal transition (EMT)-like transformation in the presence of melanoma, reminiscent of their behavior during wound healing. Surprisingly, overexpression of the EMT-transcription factor Twist in keratinocytes led to improved overall survival in zebrafish melanoma models, despite no change in tumor initiation rates. This survival benefit was attributed to reduced melanoma invasion, as confirmed by human cell co-culture assays. Single-cell RNA-sequencing revealed a unique melanoma cell cluster in the Twist-overexpressing condition, exhibiting a more differentiated, less invasive phenotype. Further analysis nominated homotypic jam3b-jam3b and pgrn-sort1a interactions between Twist-overexpressing keratinocytes and melanoma cells as potential mediators of the invasive restraint. Our findings suggest that EMT in the tumor microenvironment may paradoxically limit melanoma invasion through altered cell-cell interactions. |
| DOI | 10.7554/eLife.101974 |
| Alternate Journal | Elife |
| PubMed ID | 42378027 |
| PubMed Central ID | PMC13318302 |
| Grant List | F30CA265124 / NH / NIH HHS / United States R01CA238317 / NH / NIH HHS / United States T32GM007739 / NH / NIH HHS / United States 1K99CA266931 / CA / NCI NIH HHS / United States K00CA223016 / / National Institute of Health / F30CA236442 / / National Institute of Health / T32GM008539 / / National Institute of Health / PF-24-1316850-01-CD / / American Cancer Society / P30 CA008748 / CA / NCI NIH HHS / United States R01CA229215 / / National Institute of Health / Marie-Josée Kravis Women in Science Endeavor Postdoctoral Fellowship / / Memorial Sloan Kettering Cancer Center / Experimental Immuno-Oncology Scholars Fellowship / / Memorial Sloan Kettering Cancer Center / ASPIRE Award / / The Mark Foundation for Cancer Research / |
